Dr. Chowdhury received his Bachelor of Pharmacy and Master of Pharmacy from the University of Dhaka and obtained the Japanese Government Scholarship (MEXT) to complete his Master’s, leading to Ph.D. concentrating on Bioscience and Biotechnology. He has experience in both in-vivo and in-vitro studies. Mr. Chowdhury published his first clinical study reports on the relative bioavailability and pharmacokinetics of modified release formulations as his Master’s thesis dissertation.
His expertise in monoclonal antibody preparation by single cell pick-up method was remarkable during his higher studies in Japan. Mr. Chowdhury identified toll-like receptor 4 (TLR4) as a novel indole-3-acetic acid receptor with signaling pathways that regulate CYP1A1 and TNFα mRNA expressions in Caco-2 cells. For these fascinating research outcomes, he received the “Young Scientist Award” from the Japan Society for Bioscience, Biotechnology, and Agrochemistry (JSBBA) during his doctoral studies.
Dr. Chowdhury started his professional career as a product development expert at Novartis Bangladesh Limited (NBL). He also brings many years of teaching experience. Recently, Dr. Chowdhury has been acting as a reviewer for the reputed Elsevier publisher company.
